De Burlo Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-7,625
| Closed | -$1.4M | – | 100 |
|
|
2021
Q2 | $1.4M | Sell |
7,625
-400
| -5% | -$68.7K | 0.22% | 58 |
|
|
2021
Q1 | $1.23M | Sell |
8,025
-400
| -5% | -$61.9K | 0.22% | 60 |
|
|
2020
Q4 | $1.32M | Sell |
8,425
-75
| -0.9% | -$9.64K | 0.22% | 56 |
|
|
2020
Q3 | $9.72M | Buy |
8,500
+2,250
| +36% | +$243K | 1.77% | 27 |
|
|
2020
Q2 | $561K | Hold |
6,250
| – | – | 0.16% | 52 |
|
|
2020
Q1 | $561K | Sell |
6,250
-300
| -5% | -$29.4K | 0.16% | 52 |
|
|
2019
Q4 | $708K | Sell |
6,550
-700
| -10% | -$74.9K | 0.14% | 65 |
|
|
2019
Q3 | $710K | Sell |
7,250
-9,010
| -55% | -$1.02M | 0.16% | 60 |
|
|
2019
Q2 | $2.13M | Sell |
16,260
-300
| -2% | -$38.7K | 0.42% | 52 |
|
|
2019
Q1 | $2.24M | Sell |
16,560
-2,850
| -15% | -$354K | 0.45% | 51 |
|
|
2018
Q4 | $1.89M | Sell |
19,410
-586
| -3% | -$69.3K | 0.42% | 54 |
|
|
2018
Q3 | $2.78M | Hold |
19,996
| – | – | 0.52% | 55 |
|
|
2018
Q2 | $2.48M | Sell |
19,996
-100
| -0.5% | -$11.7K | 0.53% | 49 |
|
|
2018
Q1 | $2.24M | Hold |
20,096
| – | – | 0.49% | 49 |
|
|
2017
Q4 | $2.4M | Sell |
20,096
-354
| -2% | -$43.1K | 0.49% | 55 |
|
|
2017
Q3 | $2.87M | Sell |
20,450
-100
| -0.5% | -$13.6K | 0.64% | 45 |
|
|
2017
Q2 | $2.5M | Sell |
20,550
-400
| -2% | -$46.6K | 0.56% | 44 |
|
|
2017
Q1 | $2.54M | Sell |
20,950
-4,664
| -18% | -$601K | 0.55% | 48 |
|
|
2016
Q4 | $3.13M | Sell |
25,614
-2,070
| -7% | -$253K | 0.76% | 45 |
|
|
2016
Q3 | $3.39M | Sell |
27,684
-50
| -0.2% | -$6.44K | 0.94% | 46 |
|
|
2016
Q2 | $3.24M | Sell |
27,734
-12,825
| -32% | -$1.82M | 0.78% | 47 |
|
|
2016
Q1 | $5.65M | Sell |
40,559
-16,900
| -29% | -$2.48M | 1.63% | 19 |
|
|
2015
Q4 | $11M | Buy |
57,459
+5,389
| +10% | +$941K | 2.58% | 8 |
|
|
2015
Q3 | $8.14M | Sell |
52,070
-525
| -1% | -$95.8K | 1.91% | 19 |
|
|
2015
Q2 | $9.51M | Sell |
52,595
-14,950
| -22% | -$2.58M | 1.99% | 14 |
|
|
2015
Q1 | $11.7M | Sell |
67,545
-9,250
| -12% | -$1.67M | 2.32% | 10 |
|
|
2014
Q4 | $14.2M | Buy |
76,795
+1,600
| +2% | +$296K | 2.87% | 4 |
|
|
2014
Q3 | $12.5M | Buy |
75,195
+4,020
| +6% | +$660K | 2.76% | 6 |
|
|
2014
Q2 | $11.1M | Buy |
71,175
+225
| +0.3% | +$35.5K | 2.52% | 9 |
|
|
2014
Q1 | $10.8M | Sell |
70,950
-2,700
| -4% | -$429K | 2.6% | 10 |
|
|
2013
Q4 | $9.79M | Sell |
73,650
-55,250
| -43% | -$6.63M | 2.34% | 10 |
|
|
2013
Q3 | $15M | Sell |
128,900
-925
| -0.7% | -$101K | 4.08% | 1 |
|
|
2013
Q2 | $12M | Buy |
+129,825
| New | +$12.5M | 3.55% | 3 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM